Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.125
Bid: 10.75
Ask: 11.50
Change: 0.00 (0.00%)
Spread: 0.75 (6.977%)
Open: 11.125
High: 11.125
Low: 11.125
Prev. Close: 11.125
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oxford Technology VCTs In Mixed Quarter Amid Scancell Rise, Ixaris Hit

Mon, 21st Dec 2020 19:39

(Alliance News) - Oxford Technology VCT PLC on Friday said its third-quarter net asset value per share inched higher, helped by share price increases for investee Scancell Holdings PLC.

Oxford Technology said its NAV per share at November 30 was 38.6 pence, up 6.6% quarter-on-quarter from 36.2p.

"This increase is mainly attributable to the rise in share price of Scancell (8.0p to 11.5p)," Oxford Technology said.

"As previously advised, 236,620 shares in Scancell were disposed of following the sharp share price rise on AIM surrounding news about the novel DNA vaccine against Covid-19 being worked on by Scancell. Apart from this, the portfolio was unchanged during the quarter."

Oxford Technology 2 VCT PLC, Oxford Technology 3 VCT PLC and Oxford Technology 4 VCT PLC also reported third-quarter NAV per share figures.

At Oxford Technology 2's NAV per share rose 0.8% quarter-on-quarter to 24.5p, also attributed to Scancell.

Oxford Technology 3's NAV per share fell 42% to 38.4p, "mainly attributable to the fall in the valuation of Ixaris Holdings which continues to suffer from the global decline in travel and hotel business due to the current pandemic".

Oxford Technology 4's November 30 NAV per share was unchanged quarter-on-quarter at 28.8p.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
30 Apr 2021 14:30

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares

Read more
19 Feb 2021 20:13

IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares

IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares

Read more
19 Feb 2021 12:40

IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares

IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares

Read more
17 Feb 2021 16:22

IN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares

IN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares

Read more
3 Feb 2021 14:53

Scancell ends clinical development partnership with Cancer Research UK

(Sharecast News) - Novel immunotherapy developer Scancell updated the market on its SCIB2 clinical development partnership with Cancer Research UK on Wednesday, reporting that due to the impact of the Covid-19 pandemic and Cancer Research UK's re-evaluation of its collaboration model, the parties had agreed to end their clinical development partnership.

Read more
3 Feb 2021 11:20

CORRECT: AIM WINNERS & LOSERS: Brave Bison Charges Ahead

CORRECT: AIM WINNERS & LOSERS: Brave Bison Charges Ahead

Read more
3 Feb 2021 11:11

AIM WINNERS & LOSERS: Brave Bison Charges Ahead On Contract Win

AIM WINNERS & LOSERS: Brave Bison Charges Ahead On Contract Win

Read more
3 Feb 2021 09:48

Scancell Assessing SCIB2 Options As Cancer Research UK Pact Ends

Scancell Assessing SCIB2 Options As Cancer Research UK Pact Ends

Read more
29 Jan 2021 15:05

IN BRIEF: Scancell Posts Interim Pretax Loss; To Develop Virus Vaccine

IN BRIEF: Scancell Posts Interim Pretax Loss; To Develop Virus Vaccine

Read more
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more
18 Dec 2020 10:26

Scancell Shares Rise As It Chooses Vaccine Candidate For Development

Scancell Shares Rise As It Chooses Vaccine Candidate For Development

Read more
18 Dec 2020 10:17

Scancell selects Covid-19 vaccine candidate for development and trials

(Sharecast News) - Immunotherapy developer Scancell has selected its Covid-19 vaccine candidate 'SN14' for further development and clinical trials, it announced on Friday.

Read more
16 Dec 2020 09:21

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 750,000 Shares

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 750,000 Shares

Read more
14 Dec 2020 16:59

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.